Your Tag: Innovation

Why Rare Diseases Matter for Europe’s Future Embedding Research and Innovation as Standard of Care in Rare Disease

2 October 2026

October 2 @ 10:00 am - 5:15 pm

On 13 November 2026 in Dublin, Ireland, this event will explore how research, innovation, patient partnership and EU policy can improve rare disease care and strengthen Europe’s life sciences ecosystem.

EMA launches a new pilot to advance innovative methods to animal testing

29 September 2026

The voluntary data submission framework allows developers to share data generated using New Approach Methodologies outside marketing authorisation applications and receive tailored, non-binding feedback from European regulatory experts.

Biotech Act II: European Commission opens Call for Evidence on industrial biotechnology and biomanufacturing

18 May 2026

The European Commission has opened a Call for Evidence on the upcoming Biotech Act II — with feedback open until 10 June 2026, inviting stakeholders to submit input that will help shape the initiative before a legislative proposal is prepared.

World Orphan Drug Congress USA 2026

5 December 2025

June 9 - June 12

More than 280 speakers from industry, regulators, patient organisations, investors and healthcare providers, and aims to showcase new science, technologies and policies that can accelerate orphan drug development and improve access to therapies for people living with rare conditions.

EMA public consultation on phage therapy medicinal products

25 November 2025

EMA invites comments on new quality guideline for bacteriophage‑based medicines to support safe phage therapy development in Europe.

Accelerating Innovation Through Coordinated Research Platforms: The ERDERA Approach

10 November 2025

November 12 @ 8:00 am

On November 12 at 11:00am (GMT+3) , IBG RareBoost will host Dr. Başak Uysal from the ERDERA Coordination Team. She will deliver a presentation titled “Accelerating Innovation Through Coordinated Research Platforms: The ERDERA Approach.”

EMA publishes new guidelines for non-interventional studies

2 November 2025

New EMA ICH M14 guidelines sets common international standards for non‑interventional real‑world data studies to strengthen medicine safety assessment.